Novartis AG (NOVN)

Switzerland


Symbol	Exchange	Currency
NOVN	Switzerland	CHF	Delayed
NOVNEE	Switzerland	CHF	Delayed
NOVNz	BATS Europe	CHF	Delayed
NVS	NYSE	USD	Real-time
NVSEF	OTC Markets	USD	Delayed
0QLR	London	CHF	Real-time
NVSN	Mexico	MXN	Delayed
NVSy	TradeGate	EUR	Delayed
NVSm	Buenos Aires	ARS	Delayed
N1VS34	B3	BRL	Delayed

Currency in CHF

98.29

0.00(0.00%)

Delayed Data03:35:59

Fair Value

Unlock Value

Day's Range

96.71

98.62

52 wk Range

83.63

102.72

NOVN Income Statement

Featured here, the Income Statement (earnings report) for Novartis AG, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Total Revenues

aa.aa

49,898

43,974

43,461

46,660

51,722

Total Revenues Growth

aa.aa

+2.51%

-11.87%

-1.17%

+7.36%

+10.85%

Cost Of Revenues

aa.aa

15,121

11,391

11,582

12,020

12,815

Gross Profit

aa.aa

34,777

32,583

31,879

34,640

38,907

Gross Profit Growth

aa.aa

+1.53%

-6.31%

-2.16%

+8.66%

+12.32%

Gross Profit Margin %

aa.aa

69.7%

74.1%

73.35%

74.24%

75.22%

Other Operating Expenses, Total

aa.aa

24,625

21,620

22,666

21,998

22,587

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-2.15%	-12.2%	+4.84%	-2.95%	+2.68%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	8,980	8,259	9,172	9,011	9,511
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	14,197	12,756	12,193	12,489	12,564
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,448	605	1,301	498	512

Operating Income

aa.aa

10,152

10,963

9,213

12,642

16,320

Operating Income Growth

aa.aa

+11.73%

+7.99%

-15.96%

+37.22%

+29.09%

EBIT Margin %

aa.aa

20.35%

24.93%

21.2%

27.09%

31.55%

Net Interest Expenses

aa.aa

-778

-717

-423

-228

-438

Net Interest Expenses Growth

aa.aa

-28.6%

+7.84%

+41%

+46.1%

-92.11%

Interest Expense, Total

aa.aa

-869

-787

-800

-855

-1,006

Interest And Investment Income

aa.aa

377

627

568

Other Non Operating Expenses, Total

aa.aa

504

15,239

-209

-224

-235

EBT, Excl. Unusual Items

aa.aa

9,878

25,485

8,581

12,190

15,647

Gain (Loss) On Sale Of Assets

aa.aa

724

225

Other Unusual Items, Total

aa.aa

-890

-137

-2,236

-1,643

EBT, Incl. Unusual Items

aa.aa

9,878

24,530

7,177

9,123

13,640

EBT, Incl. Unusual Items Growth

aa.aa

+10.49%

+148.33%

-70.74%

+27.11%

+49.51%

EBT, Incl. Unusual Items Margin

aa.aa

19.8%

55.78%

16.51%

19.55%

26.37%

Income Tax Expense

aa.aa

1,807

1,625

1,128

551

1,701

Net Income to Company

aa.aa

8,071

24,018

6,955

14,854

11,939

Minority Interest

aa.aa

-4

Net Income

aa.aa

8,072

24,021

6,955

14,850

11,941

Net Income Growth

aa.aa

-31.2%

+197.58%

-71.05%

+113.52%

-19.59%

Net Income Margin %

aa.aa

16.18%

54.63%

16%

31.83%

23.09%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

8,072

22,908

6,049

8,568

11,941

Basic EPS - Continuing Operations

aa.aa

3.54

10.21

2.77

4.13

5.92

Basic EPS - Continuing Operations Growth

aa.aa

+13.7%

+188.15%

-72.85%

+48.76%

+43.41%

Diluted EPS - Continuing Operations

aa.aa

3.52

10.14

2.76

4.1

5.87

Diluted EPS - Continuing Operations Growth

aa.aa

+14.29%

+188.07%

-72.78%

+48.55%

+43.17%

Basic Weighted Average Shares Outstanding

aa.aa

2,277.04

2,242.6

2,181.18

2,076.79

2,018.28

Diluted Weighted Average Shares Outstanding

aa.aa

2,296

2,260

2,197

2,092

2,035

Dividend Per Share

aa.aa

3.39

3.4

3.46

3.92

3.86

Dividend Per Share Growth

aa.aa

+8.68%

+0.29%

+1.77%

+13.24%

-1.44%

EBITDA

aa.aa

14,932

15,633

13,940

17,518

20,662

EBITDA Growth

aa.aa

+12.55%

+4.69%

-10.83%

+25.67%

+17.95%

EBITDA Margin %

aa.aa

29.93%

35.55%

32.07%

37.54%

39.95%

EBIT

aa.aa

10,152

10,963

9,213

12,642

16,320

* In Millions of USD (except for per share items)

S&P/ASX 200

7,982.00

+13.00

+0.16%

ASX 200 Futures

8,006.50

-1.5

-0.02%

ASX All Ordinaries

8,195.50

+10.00

+0.12%

US 500

5,674.10

-19.2

-0.34%

Dow Jones

42,299.70

-155.09

-0.37%

China A50 Futures

13,406.00

-115.5

-0.85%

Dollar Index

103.92

-0.072

-0.07%

Market Movers

Name	Last	Chg. %	Vol.
Fortescue Metals	16.010	-1.23%	8.96M
BHP Group Ltd	39.690	+0.13%	8.65M
Goodman Group	29.290	-3.52%	5.98M
Westpac Banking	31.890	+0.76%	5.18M
Commonwealth Bank Australia	150.430	+0.26%	1.78M
Rio Tinto Ltd	121.260	+0.97%	1.21M
CSL	252.72	+0.12%	828.63K

Name	Last	Chg. %	Vol.
Eden Energy Ltd	0.002	+100.00%	500.50K
Bounty Oil and Gas NL	0.003	+50.00%	800.33K
Enterprise Metals Ltd	0.003	+50.00%	405.00K
Vital Metals	0.003	+50.00%	2.75M
Helix Resources	0.003	+50.00%	471.20K
Kula Gold	0.008	+33.33%	5.91M
Biotron Ltd	0.004	+33.33%	198.75K

Name	Last	Chg. %	Vol.
Seafarms	0.002	-50.00%	513.11K
Thrive Tribe Technologies	0.001	-50.00%	11.84M
Lanthanein Resources	0.002	-33.33%	1.00M
Corazon Mining Ltd	0.002	-33.33%	3.81K
Investor Centre	0.002	-33.33%	389.35K
Equity Story	0.03	-27.78%	459.44K
Errawarra	0.06	-26.67%	941.56K

Trending Stocks

Name	Last	Chg. %	Vol.
BHP Group Ltd	39.690	+0.13%	8.65M
Zip	1.75	-0.57%	19.67M
The Reject Shop	6.61	+0.15%	799.62K
Pro Medicus Ltd	201.80	-3.90%	456.91K
Commonwealth Bank Australia	150.430	+0.26%	1.78M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
A Aaaa Aaaaaaaaaa	11.68	+39.63%	16.31
A Aaaaaaaaaaaaaa	1.360	+39.28%	1.89
Aa Aaaaa	10.670	+37.61%	14.68
Aaaaaaaaa Aaa	3.820	+35.25%	5.17
Aa Aa Aaa Aaaa	10.68	+34.13%	14.33
Aaa Aaaaaa	3.180	+31.47%	4.18
Aaaaa Aaaa	38.68	+25.14%	48.40

Name	Last	Upside	Fair Value
A Aaaa Aaaaaaaaaa	11.68	+39.63%	16.31
A Aaaaaaaaaaaaaa	1.360	+39.28%	1.89
Aa Aaaaa	10.670	+37.61%	14.68
Aaaaaaaaa Aaa	3.820	+35.25%	5.17
Aa Aa Aaa Aaaa	10.68	+34.13%	14.33
Aaa Aaaaaa	3.180	+31.47%	4.18
Aaaaa Aaaa	38.68	+25.14%	48.40

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Novartis AG (NOVN)

NOVN Income Statement

Trending Stocks